IMM Investment

IMM Investment is an independent venture capital firm focused on investments in venture capital, mezzanine, and infrastructure. With the longstanding trust of institutional investors, partners and investment professionals continue to create significant values for Portfolio companies, which consist of information technology, healthcare/biotech, and manufacturing.

Hyun-Chan Cho

Managing Partner

Jaeyong Cho

Senior Managing Director

Younghwan Chung

Principal, Growth Capital

Jeanrok Han

Managing Director

Chong Kang

Managing Director

Suyoung Kim

Managing Director

Meenjoo Kim

Investment Professional

Minjeong Kim

Venture Capitalist

Hyejin Kim

Managing Director

Koo CPA, JaeYun

Senior Managing Director and Division Head

Jean Lee

Managing Director

Young Seok Lee

Vice President

Da Lee

Director

YoungJoon Lee

Co-CEO and Managing Partner

Aleum Lee

Managing Director

Philip Li

Managing Director

Jinheum Paek Ph.D

Senior Managing Director

Wonki Yoon

Senior Managing Director and Division Head

Yeojung Moon Ph.D

Senior Managing Director and Division Head

Byeonggyu Kim Ph.D

Managing Director

Jiyun Jung Ph.D

Managing Director

150 past transactions

Nextin

Venture Round in 2023
Nextin specializes in defect detection technology and metrology solutions.

N.Light

Series A in 2023
N.Light is a Metaverse 3D design software that allows individuals to effortlessly turn their ideas into reality.

Medb Korea

Seed Round in 2023
Medb Korea is a medical consumer, hospital, and pharmacy-focused online medical care and prescription drug delivery platform.. Medb Korea is located in Gangnam-gu, Seoul.

OKESTRO

Series A in 2022
OKESTRO provides cloud and AIOps software solutions.

Shiftup

Venture Round in 2022
Shift up is a game design and development studio that engages in game production and promotional video and music production. Shiftup was established in 2013 by art director Kim Hyeong-tae.

Pure Harvest Smart Farms

Venture Round in 2022
Pure Harvest Smart Farms is a regional innovator in sustainable agriculture focused on the production of premium fruits and vegetables in the challenging climates of the Arab Gulf region using world-leading controlled-environment agriculture technologies. Pure Harvest seeks to leverage innovative growing technologies and horticultural best practices in order to pioneer year-round production of affordable, premium quality fresh produce.

LumanLab

Seed Round in 2022
LumanLab develops digital therapeutics to solve developmental delay problems.

ZigBang

Venture Round in 2022
ZigBang is a real estate marketplace that offers an apartment hunting app. Users on Zig Bang can search for rental properties by the number of rooms, occupants, and price. Across both mobile and web versions, the startup reports 6 million users (though those aren’t all necessarily active and there might be some overlap).

UPPTHERA

Series B in 2022
Operator of a pharmaceutical venture company aiming to develop new drugs based on protac technology. The company provides a protein degradation platform employing a ubiquitin-proteasome system in the body, enabling patients to recover from metabolic disease and several cancers including hematologic malignancy and others.

Westworld

Series A in 2022
Westworld is a visual effects company that offers VFX, virtual production, and previsualization services for film production.

OHouse

Series D in 2022
OHouse is a all-in-one lifestyle platform that integrates content, community, and commerce. The company believes that beautiful homes can change peoples' lives for the better. Its mission is to help users decorate homes with fun, ease, and confidence. OHouse revolutionizes the lifestyle(home furnishing and remodeling) market in Korea with its user-generated style gallery, which helps users discover their preferred styles before purchasing products. On top of the marketplace for home furnishing products, it provides home remodeling services. As the leading innovators of the home furnishing industry, Ohouse aims to become an lifestyle super application that provides the best customer experience. Ohouse won the Best App Award by Google Play in 2018, and its app is downloaded by more than 20 million users.

Neubility

Series A in 2022
Neubility innovates delivery industry with self-driving delivery robots and redefines how things are delivered within cities. Starting from one of the most densely populated cities in Asia, Neubility provides reliable and affordable robot delivery service with vision-based localization and self-driving technology. Founded in 2017, the company is based on Seoul, where thousands of deliveries are completed every second.

Spark Biopharma

Series C in 2022
SPARK BioPharma Co., Ltd. was established in Seoul National University in January 2016 based on the unique drug molecule diversity technology, the image-based screening technology using the unique fluorescent skeleton probe, and the target protein identification technology in the initial drug development stage. We are currently exploring and developing new drug candidates using these three core technologies, and we will continue to accelerate the development of new drugs and increase the success rate through strategic cooperation research with domestic and overseas research institutes and pharmaceutical institutions. '

Living Workshop

Series A in 2022
Living Workshop sells pet supplies, kitchen utensils, hygiene, and cleaning products.

Encina

Venture Round in 2022
Encina provides technology solutions to produce valuable renewable chemicals, predominantly, BTX from waste plastic. These chemicals form the basis from which many major consumer products are produced.

Trioar

Seed Round in 2022
Trioar is a biotechnological research company that manufacture pharmaceutical products and drugs.

BIORCHESTRA

Series C in 2022
BIORCHESTRA is a biotech company that develops RNA-based therapeutics for treating neuroinflammatory diseases. They focus on changing the therapeutic paradigm from treating the symptoms to providing a fundamental cure for diseases. BIORCHESTRA develops neuroinflammatory disease therapeutics, with a particular emphasis on comprehensive patient care. BIORCHESTRA's complementary discovery platforms range from diagnosis to treatment monitoring.

Shopl & Company

Series A in 2022
Shopl, stands for “Shop + people”, is SasS-based software trying to resolve problems such as checking field team employees’ attendance and performance, get store data and set sales targets in the retail industry. It is the right technology connecting employees at retail shops and back-office teams at Headquarters. Shopl is in full operation from 2020, and it already secured 10,000 users. Also, it is making revenue from paid customers by providing services to Global manufacturing companies. Shopl helps to manage both employees and store issues in real-time and improves employee engagement in the shop which positively impacts business performance.

Retailo Technologies

Debt Financing in 2022
Retailo is the fastest growing B2B startup in MENAP and has digitized retail supply chains in the region. Founded in July 2020 by former Careem executives Talha Ansari, Wahaj Ahmed and Mohammad Nowkhaiz, Retailo has raised $9 million in just 9 months thanks to a diverse group of international investors that include institutions from Silicon Valley, UK, and GCC and also high net worth individuals (HNWs). Headquartered in Riyadh and operational in multiple markets in MENAP, Retailo currently provides services to over 35,000 active retailers that can access more than 2,000 SKUs from the Retailo app which are delivered to them within 24-hours of order placement. Retailo’s 500+ colleagues are spread across multiple cities in MENAP and fulfil tens of thousands of retailers’ orders every month. This vast operation is managed through multiple warehouses that store inventory from hundreds of brands, many of which are direct Retailo partners. Retailo’s mission is to simplify the retail business and make supply chains easily accessible and beautifully uncomplicated. Through its high-powered app, driven teams and smart operations, Retailo will unlock the earning potential of 10 million SME retailers in MENAP and lift the economy of the entire region.

Iyuno-SDI

Venture Round in 2022
Iyuno-SDI Group is the media and entertainment industry service provider.

WELT

Series B in 2022
From Wristworn to Waistworn: WELT, the Smart Belt for Fashion & Healthcare WELT is a 'Smart Fashion Belt' that manages users’ wellness. We encourage users to embrace healthy habits while keeping in style. We promise to help the wearer better track food intake, keep tabs on the activity level, and manage weight. To do this, WELT keeps check on the overall health by measuring (1)Waist size, (2)Steps, (3)Sitting time, and (4)Overeating habits. To help users avoid metabolic risks factors, custom messages to manage these risks are given through the app via BLE. Also, its elegant design makes it look just like a regular, leather belt. Battery is rechargeable, and can stand up to more than 7 days.

Yeoshin

Series B in 2021
Yeoshin is a skin treatment information platform.

ALUX

Series C in 2021
ALUX is a content creation company that specializes in video and coding education content.

Path

Seed Round in 2021
Path provides an AI platform for managing study habits. The startup employs deep learning-based to give non-face-to-face real-time academy lectures for middle and high schools, with the goal of changing the digital education platform.

B GARAGE

Seed Round in 2021
B GARAGE is an autonomous drone and service company for warehouse inventory management. B GARAGE is an homage to Willow Garage, a widely respected robotics research company that developed an open-source robotics software platform.

Lunit

Venture Round in 2021
Lunit, abbreviated from “learning unit,” is a venture company devoted to developing advanced software for medical data analysis and interpretation via cutting-edge deep learning technology. The company's main area of expertise lies in processing medical imaging data. It envisions a near future when its systems will greatly help physicians make accurate, consistent, and efficient clinical decisions, not limited to diagnoses, through our data-driven imaging biomarker technology. The high level of our deep learning technology has been well demonstrated, ranked top 5 at ImageNet Challenge 2015, which is the world’s largest and most prestigious image recognition competition. What distinguishes our technology from that of other similar parties is the full accommodation of weakly labeled data, challenging the boundaries of human understanding in terms of pattern recognition.

Okxe

Series A in 2021
Okxe operates as an online marketplace for motorcycles.

42dot

Series A in 2021
42dot is a technology company pioneering frictionless transportation services. 42dot develops technologies and platforms integrating autonomous driving, connected vehicles, and smart city infrastructure. The company provides platforms facilitating Mobility-as-a-Service, allowing users to access various transportation modes (e.g., autonomous shuttles, and ride-sharing) through a unified digital interface.

Crowdworks

Series C in 2021
Crowdworks is challenging the current time-consuming Machine Learning workflow and establishing a new paradigm for AI model training. We provide AI training data platform with Auto-ML features and qualified 0.5M labelers to increase human-powered data accuracy. Over 430 AI leading companies have used our solution to rapidly train and deploy cutting-edge AI service.

Pure Harvest Smart Farms

Venture Round in 2021
Pure Harvest Smart Farms is a regional innovator in sustainable agriculture focused on the production of premium fruits and vegetables in the challenging climates of the Arab Gulf region using world-leading controlled-environment agriculture technologies. Pure Harvest seeks to leverage innovative growing technologies and horticultural best practices in order to pioneer year-round production of affordable, premium quality fresh produce.

GenEdit

Series A in 2021
GenEdit was founded to transform the delivery of gene therapies and enable the next generation of non-viral, gene editing-based therapeutics. GenEdit’s proprietary technology, NanoGalaxy™ platform solves current delivery challenges by systematically screening its nanoparticle library and providing safer and efficient delivery to target tissues. The company's tool makes therapeutic gene editing possible and is easier to use, faster and more accurate than previous gene-editing techniques and thus has the potential for a wide range of therapeutic applications, enabling physicians to cure incurable genetic diseases.

IMBiologics

Series A in 2021
IMBiologics is a biotechnology company that develops immunomodulatory antibody drugs for physiological balance.

Hugel Control

Post in 2021
HUGEL, Inc. strives to be a global company that continuously creates innovative products, promotes universal health, and improves the quality of life through state-of-the-art technology and creativity.

Sanigen

Series B in 2021
Sanigen is a food safety company that provides solutions for food safety on microbial genetic analysis technology.

DeepBrain AI

Series B in 2021
Deepbrain AI has proven its world-class conversational artificial intelligence technology to be highly utilizing in many areas, including broadcasting, education, and in service industry. State-of-the-art artificial intelligence technology, analogous to real people say, can be applied in a wide variety of areas. Also, it is expected that demand will increase significantly with differentiated technology in the age of diversification. In recognition of its competitiveness and value, the company has received $2M investment from IDG Capital in 2019, and up to date, it has accumulated $9.5M. In addition, the company is currently growing in partnership with major companies such as Microsoft, Kakao Partner, and SK Telecom. It is expected to accelerate its external growth and profit expansion in the new market as it is set to make inroads into the global market based on its performance so far.

Munto

Seed Round in 2021
Munto is a community platform that enables individuals to connect better online and offline depending on their interests.

DeepMetrics

Seed Round in 2021
DeepMetrics is an AI driven ICU automation platform company

SCAI Therapeutics

Series B in 2021
SCAI Therapeutics is a drug delivery platform bio-venture company for pharmaceutical industry.

Orum Therapeutics

Series B in 2021
Orum Therapeutics is a private biotech company developing a new class of therapeutic antibodies targeting cytosolic proteins for unmet medical needs in cancer and rare diseases. Orum leverages its unique cell-penetrating antibody platform, called Oromab™ to inhibit drug targets, previously undruggable by small molecules or current antibody therapeutics. In contrast to other approaches, Orum’s antibody platform can intracellularly deliver an active antibody therapeutic or payload, is easily adaptable to target different cell types and intracellular proteins, and does not require chemical modification.

Soomgo

Series C in 2021
Soomgo is South Korea's largest local service marketplace that helps connect customers to providers across over 1,000 services. The company is backed by leading investors in both the US and Korea such as Y Combinator (W17), FJ Labs, IMM, Atinum, and more.

Encina

Venture Round in 2021
Encina provides technology solutions to produce valuable renewable chemicals, predominantly, BTX from waste plastic. These chemicals form the basis from which many major consumer products are produced.

Epibiotech

Series B in 2021
Epibiotech is a healthcare center that provides hair loss treatment solutions.

MUSINSA

Venture Round in 2021
MUSINSA is a fashion business company that offers personalized curation and storytelling for various brands and products. Its platform helps brands and consumers' lifestyles by designing, creating, enjoying, and interacting with fashion. It also delivers fashion trends and information to help customers engage and interact.

PlayList

Series B in 2021
PlayList is a web drama production company that produces dramas and music content. The company's two flagship web drama series, Love Playlist and A-Teen have gained huge popularity amongst the 18-24 age segment. Playlist dramas have over 10 million subscribers and 1.3 billion views.

Unlimeat

Series B in 2021
Unlimeat is a company that produces plant-based meat. Its plant-based meat can be used in a wide range of dishes, ensuring that its plant-based meats are ideal for both Eastern and Western cuisine. It transforms perfectly edible but unloved produce that would otherwise go to waste due to size, blemishes, or cosmetic imperfections into delectable plant-based foods. The company is proud to be a member of the Upcycled Food Association.

Trenbe

Series B in 2021
Trenbe is an e-commerce company of footwear products.

Zymedi

Venture Round in 2021
Zymedi is a pharmaceutical company that develops drugs for life-threatening diseases.

Hutom

Series B in 2021
Hutom offers a surgical service platform that includes an interactive report that is used to manage patient complications and has a positive impact on the surgeon's surgical methods. Its platform begins with an intuitive, analytical diagnosis of the patient's specificity, followed by a simulated examination of the surgery via surgical video processing, recognition, analysis, and prediction.

BIORCHESTRA

Seed Round in 2020
BIORCHESTRA is a biotech company that develops RNA-based therapeutics for treating neuroinflammatory diseases. They focus on changing the therapeutic paradigm from treating the symptoms to providing a fundamental cure for diseases. BIORCHESTRA develops neuroinflammatory disease therapeutics, with a particular emphasis on comprehensive patient care. BIORCHESTRA's complementary discovery platforms range from diagnosis to treatment monitoring.
OliX is a clinical stage biotechnology company, based on their own proprietary RNA interference (RNAi) technology regulating the expression of disease-causing genes.

OHouse

Series C in 2020
OHouse is a all-in-one lifestyle platform that integrates content, community, and commerce. The company believes that beautiful homes can change peoples' lives for the better. Its mission is to help users decorate homes with fun, ease, and confidence. OHouse revolutionizes the lifestyle(home furnishing and remodeling) market in Korea with its user-generated style gallery, which helps users discover their preferred styles before purchasing products. On top of the marketplace for home furnishing products, it provides home remodeling services. As the leading innovators of the home furnishing industry, Ohouse aims to become an lifestyle super application that provides the best customer experience. Ohouse won the Best App Award by Google Play in 2018, and its app is downloaded by more than 20 million users.

flex

Series A in 2020
Flex is a human relations platform that addresses a wide range of difficulties in enterprises involving people and organizations. Flex is co-founded by Haenam (Justin) Chang.

Pinot Bio

Venture Round in 2020
Pinot Bio is a biotechnology company that specializes in developing new generation anticancer treatments.

4DReplay

Venture Round in 2020
4DReplay provides time-slicing videos that showcase any-time, any-angle highlights with an unprecedented level of detail. They specialized in developing a 4D video solution, comprised of a set of 4K cameras and video editing software. 4dReplay is a highly advanced and easy-to-use four-dimensional time slice video production system.

Big Ocean E&M

Series A in 2020
Big Ocean E&M is an entertainment media company that offers drama, film, and music production services.

Okxe

Series A in 2020
Okxe operates as an online marketplace for motorcycles.

Geninus

Venture Round in 2020
Geninus is a biotechnology company that provides clinical genome analysis solutions for precision medicine clinics.

Curocell

Series C in 2020
Curocell’s OVIS™ technology enhances immune cells to overcome immune suppression in tumor microenvironments.

MyRealTrip

Venture Round in 2020
Founded in 2012, MyRealTrip is Korea’s leading online travel platform, helping Koreans to travel abroad and domestic.

Riiid

Series D in 2020
Riiid is a global leading AI Tutor solution provider delivering creative disruption to the education market through its cutting-edge AI technology. Having launched Santa TOEIC in 2017, the firm’s first commercialized AI Tutor solution based on a deep learning algorithm which has garnered 1 million users solely in the Korean market with proven efficacy. Leveraging the firm’s highly scalable and proven AI solution, Rigid is expanding its business to new test areas as well as into new geographical markets. It currently operates Santa TOEIC in Japan and has launched Santa SAT in Vietnam. Riiid aims at replacing hard copy textbooks and traditional lectures with AI Tutor. Through the firm's technology, any individual student gains access to a personalized AI tutor that far outpaces human tutors in terms of learning efficacy at a fraction of the cost. Driving the democratization and equalization of educational opportunities, Riiid is transforming learning and the industry landscape in a remarkable and rapid fashion.

UPPTHERA

Series A in 2020
Operator of a pharmaceutical venture company aiming to develop new drugs based on protac technology. The company provides a protein degradation platform employing a ubiquitin-proteasome system in the body, enabling patients to recover from metabolic disease and several cancers including hematologic malignancy and others.

42dot

Venture Round in 2020
42dot is a technology company pioneering frictionless transportation services. 42dot develops technologies and platforms integrating autonomous driving, connected vehicles, and smart city infrastructure. The company provides platforms facilitating Mobility-as-a-Service, allowing users to access various transportation modes (e.g., autonomous shuttles, and ride-sharing) through a unified digital interface.

IDUS

Series D in 2020
IDUS is an online store that sells watches, home fabric, shoes, rings, earrings, necklaces, bracelets, phone cases, digital accessories, and home interior products. They enable customers to transact directly with sellers over the Internet via a web browser or a mobile app. Their goods benefit customers.

United Water

Venture Round in 2020
United Water is a provider of water supply and waste water treatment in China.

Swatch On

Corporate Round in 2020
Swatch On was launched under the motive to provide a variety of unique, high-quality wholesale fabrics at a reasonable price. Their team is composed of young, creative, professional and motivated individuals crazy and passionate about fashion fabric. And they are here to help you find the perfect fabric for your collection. They assure that you will have great experiences with their personalized approach to each and every client.

H2O Hospitality

Series B in 2020
H2O Hospitality is the largest vacation rental management company in Japan and Korea. H2O manages accommodation facilities without any on-site human resources by automating all the operational flows through the property management system (“PMS”) H2O developed that links and manages calendars between the guests, rooms, and housekeepers. This allows significant decrease in fixed cost of the operational expenses, increasing the yield of the facility.

Amondz

Series A in 2020
Amondz is a jewellery ecommerce platform that provides buyers and sellers with quick access to a production list, price quotations for consumers, and customer support.

Spoon Labs

Series B in 2019
Spoon Labs provides the potential of creating material that enriches people's daily lives all across the world.

WeMakePrice

Venture Round in 2019
Wemakeprice (위메프) is a Korean social commerce platform offering e-commerce and internet advertising services. IT was launched in May 2010 in Seoul, Korea.

Curiox Biosystems

Series B in 2019
Curiox is a bioinstrumentation company spun out of the Agency for Science, Technology, and Research (A*STAR) in Singapore. Curiox has become a leader in the development and commercialization of innovative assay platforms based on its expertise in surface chemistry and engineering. Curiox’s vision is to accelerate the progress of life sciences, drug discovery and diagnostics through the miniaturization and improved automation of bioassays.

Kobiolabs

Venture Round in 2019
Kobiolabs is a microbiome-based venture

True Balance

Series C in 2019
True Balance is a digital wallet owned and operated by Balancehero India Private Limited (BHI), that enables users to access utility bill payment, loan recharge, insurance, and other financial products. With 70 million users, True Balance aims to serve India with utility payments financial platform for the unbanked users to serve their money for living requirements. It was launched in 2014 by Mr. Charlie Lee as CEO, an alumnus of the University of Chicago.

GI Innovation

Series B in 2019
GI Innovation is a South Korean bio-venture company, integrating basic science and translational innovation in developing biologics for patients around the world. GI Innovation’s strategic focus is on immuno-oncology and inflammation/immunology diseases. GI Innovation has established GI-SMART platform technology that is designed to accelerate the development of biologics through the efficient optimization of multi-targeting fusion protein therapeutics with high quality and high productivity.

Rainist

Series C in 2019
Rainist is a Korean software company that recommends financial products based on one's life patterns. Its service is BankSalad, a credit card recommendation service based on one's spending patterns.

Oncorus

Series B in 2019
Oncorus, Inc. is a lean early-stage biotechnology company developing a next-generation immunotherapy platform to treat cancer. Oncorus was founded MPM Managing Director Mitch Finer, a well-known biotechnology entrepreneur. Oncorus is a leader in corporate philanthropy, and has taken a pledge to donate a portion of product sales to fund promising cancer research and to support cancer care in the developing world.

Ground

Series B in 2019
GROUND provides innovative solutions based on the advanced technologies in the logistics and distribution industry (LogiTech®), aiming to achieve Intelligent Logistics®, its original concept that applies the latest technologies such as AI and robotics.

Orum Therapeutics

Series B in 2019
Orum Therapeutics is a private biotech company developing a new class of therapeutic antibodies targeting cytosolic proteins for unmet medical needs in cancer and rare diseases. Orum leverages its unique cell-penetrating antibody platform, called Oromab™ to inhibit drug targets, previously undruggable by small molecules or current antibody therapeutics. In contrast to other approaches, Orum’s antibody platform can intracellularly deliver an active antibody therapeutic or payload, is easily adaptable to target different cell types and intracellular proteins, and does not require chemical modification.

Riiid

Series C in 2019
Riiid is a global leading AI Tutor solution provider delivering creative disruption to the education market through its cutting-edge AI technology. Having launched Santa TOEIC in 2017, the firm’s first commercialized AI Tutor solution based on a deep learning algorithm which has garnered 1 million users solely in the Korean market with proven efficacy. Leveraging the firm’s highly scalable and proven AI solution, Rigid is expanding its business to new test areas as well as into new geographical markets. It currently operates Santa TOEIC in Japan and has launched Santa SAT in Vietnam. Riiid aims at replacing hard copy textbooks and traditional lectures with AI Tutor. Through the firm's technology, any individual student gains access to a personalized AI tutor that far outpaces human tutors in terms of learning efficacy at a fraction of the cost. Driving the democratization and equalization of educational opportunities, Riiid is transforming learning and the industry landscape in a remarkable and rapid fashion.

Soomgo

Series B in 2019
Soomgo is South Korea's largest local service marketplace that helps connect customers to providers across over 1,000 services. The company is backed by leading investors in both the US and Korea such as Y Combinator (W17), FJ Labs, IMM, Atinum, and more.

GeneMedicine

Series A in 2019
GeneMedicine(GM) is a clinical stage biopharmaceutical company focused on developing next-generation viral immunotherapies, aiming to transform the therapeutic outcomes for cancer patients. Using their proprietary adenovirus platform, GM is developing several pipeline products that can be intratumorally and intravenously administered to selectively attack and eradicate tumor cells as well as potently stimulating multiple arms of antitumor immune response. GM’s viral immunotherapy has proven effective as both a standalone therapy and in combination with current standard of care, including immune checkpoint inhibitors (ICI). Intratumoral administration of GM oncolytic adenovirus offers several advantages over competitor products; (1) higher level of virus accumulation and localization in tumor tissues and (2) lower off-target systemic exposure, ultimately exerting potent therapeutic effect with minimal systemic toxicity. Our pipeline can effectively treat wide range of tumor types, including breast cancers (triple-negative and hormone receptor-positive), prostate cancer, melanoma, and non-melanoma skin cancer, desmoplastic cancers (like pancreatic cancer), and injectable visceral tumors that have spread to the liver, such as metastases from colorectal and lung cancer. To treat metastatic and recurrent cancers in late-stage cancer patients, GM has developed systemic delivery platform for oncolytic viruses that avoids rapid blood clearance and inactivation by the immune system and various blood components, which are known to severely hamper the clinical effectiveness of intravenously administered viral immunotherapies. Systemic delivery represents an important next step in successful oncolytic virus treatments for intractable and metastatic cancers that have disseminated to multiple organs. Headquartered in the Fusion Technology Center, Seoul, South Korea, GM is a leader in oncolytic immunotherapy. GM’s potent multi-armed oncolytic viral platform (GM-OAd) is a culmination of multiple proprietary oncolytic adenovirus technologies, which has been intelligently designed and carefully optimized to ensure maximum therapeutic benefit in patients. The company was founded in 2014 and has been the recipient of Korean venture backing and grants. GM-OAd is a proprietary oncolytic adenovirus that has been extensively engineered to maximize its safety, cancer selectivity, and anti-tumor activity. GM-OAd-mediated oncolysis results in immunogenic cell death to trigger robust antitumor immune activation and memory formation to ensure long-term therapeutic benefit against cancer. GM has a highly scalable, low cost manufacturable platform offering highly versatile, innovative treatment options for patients with advanced or metastatic tumors. Further, they have a deep portfolio of unique, globally protected, intellectual property including patents for systemic delivery platform for oncolytic virus and technologies that ensure effective degradation of tumor extracellular matrix to enhance the intratumoral permeation and distribution of other conventional cancer drugs, like chemotherapy, targeted antibodies, and ICI, to achieve strong synergistic potential. GeneMedicine is interested in assessing your interest in partnering their assets.

Seculetter

Venture Round in 2019
SecuLetter is a cutting-edge solution of SecuLetter is able to detect unknown attacks with hybrid approaches,static and dynamic analysis even though cyber criminals recently hide malicious links and attachments to bypass existing email security systems.

MyRealTrip

Venture Round in 2019
Founded in 2012, MyRealTrip is Korea’s leading online travel platform, helping Koreans to travel abroad and domestic.

APR Corporation

Venture Round in 2019
APR is a global beauty-tech company expands beyond beauty with “Medicube” leading the charge.

Amondz

Series A in 2019
Amondz is a jewellery ecommerce platform that provides buyers and sellers with quick access to a production list, price quotations for consumers, and customer support.

Paean Biotechnology

Venture Round in 2019
Paean Biotechnology is a biopharmaceutical company that develops mitochondrial medicinal products.

MEATBOX

Series C in 2018
MEATBOX is a B2B-based online commerce platform for livestock products. MEATBOX introduces 'My Box,' a storage space-sharing service for restaurants and butcher shops, where customers can store frozen meat products purchased from Meatbox and receive the delivery as needed. Meatbox explained that Mybox not only significantly reduces costs for members, but it also has the advantage of being able to respond quickly with sufficient inventory purchased in advance even when inventory demand spikes unexpectedly. The My Box service is also available on the Meatbox PC and mobile apps, allowing one to make one-touch requests for delivery of stored products as well as confirmation of receipt and release.

Gentle Monster

Venture Round in 2018
Gentle Monster operates as a luxury eyewear brand, operating under a unique philosophy and perspective, devoted towards a vision of “weird beauty” through “High-end experimentation”.

EuBiologics

Venture Round in 2018
EuBiologics Co., Ltd. is a South Korean biopharmaceutical company focused on developing and supplying vaccines aimed at addressing epidemics and antibiotic resistance. The company offers several products, including Euvchol, an oral cholera prevention vaccine, and CRM197, a diphtheria toxin mutant vaccine. In addition to its vaccine portfolio, EuBiologics provides a range of customized services related to biopharmaceutical development, encompassing mammalian and microbial cell-derived products. These services include cell line development, GMP production, validation, and regulatory support. The company also specializes in manufacturing recombinant biological products and antibody therapeutics, along with offering process, formulation, and analytical method development. Furthermore, EuBiologics provides contract testing services, which cover lot release, stability, raw material, and method validation testing. Founded in 2010 and headquartered in Seoul, EuBiologics aims to contribute to global public health through its innovative solutions.

Olipass

Venture Round in 2018
OliPass is always collaborating to develop new ways to give a happy and healthy existence for everyone on the planet. OliPass Corporation is dedicated to changing people's perceptions of life sciences and improving their quality of life.

Kmong

Series B in 2018
Kmong (크몽) is a Korean online talent market that enables individuals to both sell and buy services. Its categories include design, marketing, document, business, computer, music and video, life services, and handmade. Users can post up their services with a price quote on the appropriate category, which will be seen and picked up by prospective buyers. Its mobile application is available for Android devices. Kmong was established in June 2012 in Gyeongsangnam-do, Korea.

CARVI

Venture Round in 2018
CARVI offers distinct solutions in the field of mobility Insurtech. Their precise analysis of the driver's future accident probability and current driving habits is the most effective method of reducing car accidents.

TiumBio

Series B in 2018
TiumBio is an R&D company that creates innovative new drugs. The company provides services for cancer, hemophilia, type 2 diabetes, and idiopathic pulmonary fibrosis. TiumBio develops NCE401, NCE403, NBP604, and NBP611. NCE401 is a substance for the treatment of fibrosis while NCE403 is for treating endomitriosis, NBP604 is for hemophilia and works a neutralizing antibody, and lastly NBP611, for the treatment of hemophilia B.

Big Hit Music

Corporate Round in 2018
is a South Korean entertainment company established in 2005 by Bang Si-hyuk. It currently manages soloist Lee Hyun and idol group BTS.

Hutom

Series A in 2018
Hutom offers a surgical service platform that includes an interactive report that is used to manage patient complications and has a positive impact on the surgeon's surgical methods. Its platform begins with an intuitive, analytical diagnosis of the patient's specificity, followed by a simulated examination of the surgery via surgical video processing, recognition, analysis, and prediction.

OHouse

Series A in 2018
OHouse is a all-in-one lifestyle platform that integrates content, community, and commerce. The company believes that beautiful homes can change peoples' lives for the better. Its mission is to help users decorate homes with fun, ease, and confidence. OHouse revolutionizes the lifestyle(home furnishing and remodeling) market in Korea with its user-generated style gallery, which helps users discover their preferred styles before purchasing products. On top of the marketplace for home furnishing products, it provides home remodeling services. As the leading innovators of the home furnishing industry, Ohouse aims to become an lifestyle super application that provides the best customer experience. Ohouse won the Best App Award by Google Play in 2018, and its app is downloaded by more than 20 million users.

Day1 Company

Series A in 2018
Day 1 Company (formerly Fast Campus) is Korea’s fastest-growing Life-Changing Education startup.

StyleShare

Series C in 2018
StyleShare is a realtime mobile and online platform that allows users to share and receive updates on fashion and beauty. With millions of users from 120 different countries, StyleShare is the top mobile platform for those interested in everyday fashion and beauty. Based in Seoul, South Korea, StyleShare has garnered the attention of VOGUE, Instyle, and Elle Japan as the No. 1 mobile fashion application.

ImmunoForge

Venture Round in 2018
ImmunoForge is a developer of a new drug intended for treating sarcopenia and cancer. The company has a solution for sarcopenia based on its drug repurposing patents as well as a strong kinase inhibitor pipeline for genomically defined rare cancers, such as chronic myelogenous leukemia, enabling patients to get cured quickly.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.